Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiovascular Surgery Devices Pipeline Market Report Overview 

Cardiovascular surgery devices include devices used in cardiovascular surgeries such as coronary artery bypass surgery. The cardiovascular surgery devices pipeline market research report provides comprehensive information about the cardiovascular surgery devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report provides information about various pipeline products and their estimated approval dates.

Cardiovascular Surgery Devices Pipeline Products Market Segments

The key segments in the cardiovascular surgery devices pipeline products market are cardiac ablation devices, coronary artery bypass graft surgery, beating heart surgery systems, oxygenators, perfusion disposables, and positioners. Cardiac ablation devices have the highest number of pipeline products in the cardiovascular surgery devices pipeline products market as of February 2023. 

Beating Heart Surgery Systems: Beating heart surgery systems are utilized while performing an off-pump Coronary Artery Bypass Grafting (CABG) procedure. Surgeons use special positioners and stabilizers to position and stabilize the part of the heart on which they are operating. The heart continues to beat during the operation. Surgery on a beating heart helps reduce the risk of complications associated with temporarily stopping the heart during surgery. 

Perfusion Disposables: Perfusion disposables consist of disposable items used during cardio pulmonary bypass surgery. These include custom packs and oxygenators.

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Segments, 2023 (%)

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Segments, 2023 (%)

For more segment insights into the cardiovascular surgery devices pipeline products market, download a free report sample

Cardiovascular Surgery Devices Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, Europe, China, Canada, Israel, Germany, India, Australia, and the Czech Republic among others. The US is the leading territory in the cardiovascular surgery devices pipeline products market.

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Territories, 2023 (%)

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Territories, 2023 (%)

 For more territory insights into the cardiovascular surgery devices pipeline products market, download a free report sample

Cardiovascular Surgery Devices Pipeline Products Market Segmentation by Regulatory Paths

The cardiovascular surgery devices pipeline report provides detailed insights into the pipeline products by a regulatory path including 510(k), PMA, CE, NMPA, MDL, Ninsho, TGA, ICAC, and MDITAC. Most of the products follow the 510(K) pathway to enter the market.

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Regulatory Paths, 2023 (%)

Cardiovascular Surgery Devices Pipeline Products Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the cardiovascular surgery devices pipeline products market, download a free report sample

Cardiovascular Surgery Devices Pipeline Products Market - Competitive Landscape

Some of the leading companies in the cardiovascular surgery devices pipeline products market are 3DT Holdings LLC, 510 Kardiac Devices Inc, Abiomed Inc, AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Advanced Catheter Therapies Inc, AdvanSource Biomaterials Corporation, and Affera Inc.

3DT Holdings LLC: 3DT Holdings LLC (3DT) is a contract research organization that offers drug development and manufacturing services. It develops, manufactures, and markets drugs for the treatment of cardiovascular, metabolic disorders, diabetes, and vascular diseases.

510 Kardiac Devices Inc: 510 Kardiac Devices Inc a subsidiary of Keystone Heart Ltd, is a development-stage company that provides novel cardiovascular devices through which cardiologists can perform procedures at targeted locations within the structures of the heart.

For more information on the leading players in the cardiovascular surgery devices pipeline products market, download a free report sample

Cardiovascular Surgery Devices Pipeline Products Market Report Overview

Key Territories The US, Europe, China, Canada, Israel, Germany, India, Australia, and the Czech Republic
Key Regulatory Paths 510(k), PMA, CE, NMPA, MDL, Ninsho, TGA, ICAC, and MDITAC
Key Segments Cardiac Ablation Devices, Coronary Artery Bypass Graft Surgery, Beating Heart Surgery Systems, Oxygenators, Perfusion Disposables, and Positioners
Leading Companies 3DT Holdings LLC, 510 Kardiac Devices Inc, Abiomed Inc, AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Advanced Catheter Therapies Inc, AdvanSource Biomaterials Corporation, and Affera Inc

Segments Covered in the Report 

Cardiovascular Surgery Devices Pipeline Products Territorial Outlook (Number of Products, 2023)

  • The US
  • Europe
  • China
  • Canada
  • Israel
  • Germany
  • India
  • Australia
  • Czech Republic

Cardiovascular Surgery Devices Pipeline Products Segments Outlook (Number of Products, 2023)

  • Cardiac Ablation Devices
  • Coronary Artery Bypass Graft Surgery
  • Beating Heart Surgery Systems
  • Oxygenators
  • Perfusion Disposables
  • Positioners

Cardiovascular Surgery Devices Pipeline Products Regulatory Paths Outlook (Number of Products, 2023)

  • 510(k)
  • PMA
  • CE
  • NMPA
  • MDL
  • Ninsho
  • TGA
  • ICAC
  • MDITAC

Scope

  • Extensive coverage of the cardiovascular surgery devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of cardiovascular surgery devices and lists all their pipeline projects
  • The coverage of pipeline products is based on various stages of development ranging from early development to the approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of cardiovascular surgery devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3DT Holdings LLC
510 Kardiac Devices Inc
Abiomed Inc
AblaCor Medical Corporation
AccuPulse Medical Technology Co Ltd
Acutus Medical Inc
Adagio Medical Inc.
Advanced Catheter Therapies Inc
AdvanSource Biomaterials Corporation
Affera Inc
AFreeze GmbH
Amt Medical BV
AngioDynamics Inc
Apaxis Medical Inc
Applied Medical Resources Corporation
APT Medical Inc
Arga Medtech SA
ArtiFex Medical GmbH
Atrian Medical Ltd
AtriCure Inc
Axcelon Biopolymers Corp
Axon Therapies Inc
Baylis Medical Company Inc
Beth Israel Deaconess Medical Center
Biosense Webster Inc
Boston Children's Hospital
Boston Scientific Corp
CardioPolymers Inc
CardioPrecision Ltd
CardioScout, LLC
Cardious Inc
Cardiovascular Systems Inc
catheter precision Inc
Centre Hospitalier Universitaire de Nice
Cincinnati Children's Hospital Medical Center
CircumFix Solutions Inc
Corazon Technologies, Inc.
Corfigo Inc
Coridea, LLC
Coromedic Ltd.
CPSI Biotech
Cryofocus Medtech Shanghai Co Ltd
Cytograft Tissue Engineering Inc (Inactive)
Daidalos Solutions BV
Edwards Lifesciences Corp
Elana bv
Emory University
Endoron Medical Ltd
enVVeno Medical Corp
Epiendoaf Inc
EpiEP, Inc.
Excision Medical Inc
Farapulse Inc
Galaxy Medical Products Inc
Graft-Loc Inc.
H. Lee Moffitt Cancer Center & Research Institute Inc
Hadassah Medical Center
Hangzhou Nuocheng Medical Technology Co Ltd
Hangzhou Nuomao Medical Technology Co Ltd
HeartLander Surgical, Inc.
HeartStitch Inc.
Helical Solutions, Inc. (Inactive)
Huifeng Biotechnology (Shanghai) Co Ltd
iiTech BV
Insight Lifetech Co Ltd
Japan Lifeline Co Ltd
Johns Hopkins University
Kardium Inc
LaunchPoint Technologies Inc
LeMaitre Vascular Inc
Lepu Medical Technology (Beijing) Co Ltd
LuxCath, LLC
McGill University
Medical 21 Inc
Medtronic Plc
MicroPort Scientific Corp
Microsurgical Innovations Inc
Most Cardio LLC
Myocardial Assist Systems and Technology LLC
National Science and Technology Development Agency
Neograft Technologies Inc
Nido Surgical LLC
Northwestern University
Occlutech International AB
OrbusNeich
Pavmed Inc
Peca Labs Inc
PeriCor LLC
PetVivo Holdings Inc
Prekubator TTO
Protaryx Medical
Rafael Medical Technologies, Inc.
RegenMedTX LLC
Replication Medical Inc
RWTH Aachen University
SeamVad Ltd.
Shanghai Antec Medical Technology Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shanghai Keku Medical Technology Co Ltd
Shanghai Weiqi Medical Equipment Co Ltd
Shanghai Xuanyu Medical Equipment Co Ltd
Sichuan Jinjiang Electronic Science and Technology Co Ltd
Southern Research Institute
Spectranetics Corp
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
Sunnybrook Health Sciences Centre
Surg Solutions SL
Suzhou Aikemai Medical Technology Co Ltd
Synovis Micro Companies Alliance Inc
Tau Pnu Medical Co., Ltd.
The Chaim Sheba Medical Center
Thermedical Inc
Thoratec LLC
Tianjin Intelligent Health Medical Co Ltd
Tissue Regeneration Technologies LLC
Toray Medical Co Ltd
TransMed7 LLC
Transmural systems LLC
Tufts Medical Center
University College London
University of Arizona
University of California Davis
University of California Los Angeles
University of Chicago
University of Iowa
University of Montreal
University of Nebraska
University of Nebraska Medical Center
Varian Medical Systems Inc
Vigor Medical Technologies Ltd.
Virginia Polytechnic Institute and State University
Vivonics Inc
VytronUS Inc
Xeltis AG

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 11

|1.2 List of Figures 23

2 Introduction 24

2.1 Cardiovascular Surgery Devices Overview 24

3 Products under Development 25

3.1 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 25

3.2 Cardiovascular Surgery Devices – Pipeline Products by Segment 26

3.3 Cardiovascular Surgery Devices – Pipeline Products by Territory 27

3.4 Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 28

3.5 Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 29

3.6 Cardiovascular Surgery Devices – Ongoing Clinical Trials 30

4 Cardiovascular Surgery Devices – Pipeline Products under Development by Companies 31

4.1 Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development 31

4.2 Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 36

5 Cardiovascular Surgery Devices Companies and Product Overview 41

5.1 3DT Holdings LLC Company Overview 41

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.2 510 Kardiac Devices Inc Company Overview 42

5.2.1 510 Kardiac Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.3 Abiomed Inc Company Overview 43

5.3.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.4 AblaCor Medical Corporation Company Overview 44

5.4.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 44

5.5 AccuPulse Medical Technology Co Ltd Company Overview 46

5.5.1 AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.6 Acutus Medical Inc Company Overview 48

5.6.1 Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.7 Adagio Medical Inc. Company Overview 51

5.7.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

5.8 Advanced Catheter Therapies Inc Company Overview 57

5.8.1 Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.9 AdvanSource Biomaterials Corporation Company Overview 58

5.9.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 58

5.10 Affera Inc Company Overview 59

5.10.1 Affera Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.11 AFreeze GmbH Company Overview 66

5.11.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

5.12 Amt Medical BV Company Overview 67

5.12.1 Amt Medical BV Pipeline Products & Ongoing Clinical Trials Overview 67

5.13 AngioDynamics Inc Company Overview 70

5.13.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.14 Apaxis Medical Inc Company Overview 71

5.14.1 Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71

5.15 Applied Medical Resources Corporation Company Overview 74

5.15.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 74

5.16 APT Medical Inc Company Overview 75

5.16.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.17 Arga Medtech SA Company Overview 77

5.17.1 Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview 77

5.18 ArtiFex Medical GmbH Company Overview 81

5.18.1 ArtiFex Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 81

5.19 Atrian Medical Ltd Company Overview 82

5.19.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

5.20 AtriCure Inc Company Overview 85

5.20.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.21 Axcelon Biopolymers Corp Company Overview 91

5.21.1 Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 91

5.22 Axon Therapies Inc Company Overview 92

5.22.1 Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.23 Baylis Medical Company Inc Company Overview 95

5.23.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.24 Beth Israel Deaconess Medical Center Company Overview 96

5.24.1 Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 96

5.25 Biosense Webster Inc Company Overview 98

5.25.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 98

5.26 Boston Children’s Hospital Company Overview 101

5.26.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 101

5.27 Boston Scientific Corp Company Overview 104

5.27.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 104

5.28 CardioPolymers Inc Company Overview 105

5.28.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.29 CardioPrecision Ltd Company Overview 106

5.29.1 CardioPrecision Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

5.30 CardioScout, LLC Company Overview 107

5.30.1 CardioScout, LLC Pipeline Products & Ongoing Clinical Trials Overview 107

5.31 Cardious Inc Company Overview 108

5.31.1 Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.32 Cardiovascular Systems Inc Company Overview 109

5.32.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.33 catheter precision Inc Company Overview 110

5.33.1 catheter precision Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.34 Centre Hospitalier Universitaire de Nice Company Overview 111

5.34.1 Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 111

5.35 Cincinnati Children’s Hospital Medical Center Company Overview 112

5.35.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 112

5.36 CircumFix Solutions Inc Company Overview 113

5.36.1 CircumFix Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.37 Corazon Technologies, Inc. Company Overview 114

5.37.1 Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

5.38 Corfigo Inc Company Overview 115

5.38.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 115

5.39 Coridea, LLC Company Overview 116

5.39.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 116

5.40 Coromedic Ltd. Company Overview 117

5.40.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 117

5.41 CPSI Biotech Company Overview 119

5.41.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 119

5.42 Cryofocus Medtech Shanghai Co Ltd Company Overview 123

5.42.1 Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 123

5.43 Cytograft Tissue Engineering Inc (Inactive) Company Overview 126

5.43.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 126

5.44 Daidalos Solutions BV Company Overview 128

5.44.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 128

5.45 Edwards Lifesciences Corp Company Overview 131

5.45.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 131

5.46 Elana bv Company Overview 135

5.46.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview 135

5.47 Emory University Company Overview 136

5.47.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 136

5.48 Endoron Medical Ltd Company Overview 137

5.48.1 Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

5.49 enVVeno Medical Corp Company Overview 138

5.49.1 enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 138

5.50 Epiendoaf Inc Company Overview 141

5.50.1 Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview 141

5.51 EpiEP, Inc. Company Overview 142

5.51.1 EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142

5.52 Excision Medical Inc Company Overview 143

5.52.1 Excision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 143

5.53 Farapulse Inc Company Overview 144

5.53.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 144

5.54 Galaxy Medical Products Inc Company Overview 153

5.54.1 Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 153

5.55 Graft-Loc Inc. Company Overview 156

5.55.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 156

5.56 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview 157

5.56.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.57 Hadassah Medical Center Company Overview 158

5.57.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 158

5.58 Hangzhou Nuocheng Medical Technology Co Ltd Company Overview 160

5.58.1 Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

5.59 Hangzhou Nuomao Medical Technology Co Ltd Company Overview 161

5.59.1 Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

5.60 HeartLander Surgical, Inc. Company Overview 164

5.60.1 HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164

5.61 HeartStitch Inc. Company Overview 165

5.61.1 HeartStitch Inc. Pipeline Products & Ongoing Clinical Trials Overview 165

5.62 Helical Solutions, Inc. (Inactive) Company Overview 166

5.62.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 166

5.63 Huifeng Biotechnology (Shanghai) Co Ltd Company Overview 167

5.63.1 Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.64 iiTech BV Company Overview 168

5.64.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 168

5.65 Insight Lifetech Co Ltd Company Overview 170

5.65.1 Insight Lifetech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

5.66 Japan Lifeline Co Ltd Company Overview 172

5.66.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

5.67 Johns Hopkins University Company Overview 173

5.67.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 173

5.68 Kardium Inc Company Overview 174

5.68.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 174

5.69 LaunchPoint Technologies Inc Company Overview 181

5.69.1 LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 181

5.70 LeMaitre Vascular Inc Company Overview 182

5.70.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 182

5.71 Lepu Medical Technology (Beijing) Co Ltd Company Overview 185

5.71.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

5.72 LuxCath, LLC Company Overview 188

5.72.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 188

5.73 McGill University Company Overview 189

5.73.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 189

5.74 Medical 21 Inc Company Overview 190

5.74.1 Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 190

5.75 Medtronic Plc Company Overview 191

5.75.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 191

5.76 MicroPort Scientific Corp Company Overview 196

5.76.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 196

5.77 Microsurgical Innovations Inc Company Overview 199

5.77.1 Microsurgical Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview 199

5.78 Most Cardio LLC Company Overview 200

5.78.1 Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 200

5.79 Myocardial Assist Systems and Technology LLC Company Overview 201

5.79.1 Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 201

5.80 National Science and Technology Development Agency Company Overview 202

5.80.1 National Science and Technology Development Agency Pipeline Products & Ongoing Clinical Trials Overview 202

5.81 Neograft Technologies Inc Company Overview 203

5.81.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 203

5.82 Nido Surgical LLC Company Overview 204

5.82.1 Nido Surgical LLC Pipeline Products & Ongoing Clinical Trials Overview 204

5.83 Northwestern University Company Overview 205

5.83.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 205

5.84 Occlutech International AB Company Overview 206

5.84.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 206

5.85 OrbusNeich Company Overview 210

5.85.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 210

5.86 Pavmed Inc Company Overview 211

5.86.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 211

5.87 Peca Labs Inc Company Overview 213

5.87.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 213

5.88 PeriCor LLC Company Overview 214

5.88.1 PeriCor LLC Pipeline Products & Ongoing Clinical Trials Overview 214

5.89 PetVivo Holdings Inc Company Overview 215

5.89.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 215

5.90 Prekubator TTO Company Overview 216

5.90.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 216

5.91 Protaryx Medical Company Overview 217

5.91.1 Protaryx Medical Pipeline Products & Ongoing Clinical Trials Overview 217

5.92 Rafael Medical Technologies, Inc. Company Overview 218

5.92.1 Rafael Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 218

5.93 RegenMedTX LLC Company Overview 219

5.93.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 219

5.94 Replication Medical Inc Company Overview 220

5.94.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 220

5.95 RWTH Aachen University Company Overview 221

5.95.1 RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview 221

5.96 SeamVad Ltd. Company Overview 222

5.96.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 222

5.97 Shanghai Antec Medical Technology Co Ltd Company Overview 223

5.97.1 Shanghai Antec Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 223

5.98 Shanghai HeartCare Medical Technology Co Ltd Company Overview 225

5.98.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

5.99 Shanghai Keku Medical Technology Co Ltd Company Overview 226

5.99.1 Shanghai Keku Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

5.100 Shanghai Weiqi Medical Equipment Co Ltd Company Overview 228

5.100.1 Shanghai Weiqi Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

5.101 Shanghai Xuanyu Medical Equipment Co Ltd Company Overview 231

5.101.1 Shanghai Xuanyu Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 231

5.102 Sichuan Jinjiang Electronic Science and Technology Co Ltd Company Overview 232

5.102.1 Sichuan Jinjiang Electronic Science and Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 232

5.103 Southern Research Institute Company Overview 234

5.103.1 Southern Research Institute Pipeline Products & Ongoing Clinical Trials Overview 234

5.104 Spectranetics Corp Company Overview 235

5.104.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 235

5.105 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 236

5.105.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 236

5.106 Stanford University Company Overview 238

5.106.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 238

5.107 Sunnybrook Health Sciences Centre Company Overview 240

5.107.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview 240

5.108 Surg Solutions SL Company Overview 241

5.108.1 Surg Solutions SL Pipeline Products & Ongoing Clinical Trials Overview 241

5.109 Suzhou Aikemai Medical Technology Co Ltd Company Overview 242

5.109.1 Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 242

5.110 Synovis Micro Companies Alliance Inc Company Overview 244

5.110.1 Synovis Micro Companies Alliance Inc Pipeline Products & Ongoing Clinical Trials Overview 244

5.111 Tau Pnu Medical Co., Ltd. Company Overview 245

5.111.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 245

5.112 The Chaim Sheba Medical Center Company Overview 248

5.112.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 248

5.113 Thermedical Inc Company Overview 249

5.113.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 249

5.114 Thoratec LLC Company Overview 253

5.114.1 Thoratec LLC Pipeline Products & Ongoing Clinical Trials Overview 253

5.115 Tianjin Intelligent Health Medical Co Ltd Company Overview 254

5.115.1 Tianjin Intelligent Health Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 254

5.116 Tissue Regeneration Technologies LLC Company Overview 255

5.116.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 255

5.117 Toray Medical Co Ltd Company Overview 256

5.117.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.118 TransMed7 LLC Company Overview 257

5.118.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 257

5.119 Transmural systems LLC Company Overview 258

5.119.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 258

5.120 Tufts Medical Center Company Overview 262

5.120.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 262

5.121 University College London Company Overview 263

5.121.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 263

5.122 University of Arizona Company Overview 264

5.122.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 264

5.123 University of California Davis Company Overview 266

5.123.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 266

5.124 University of California Los Angeles Company Overview 267

5.124.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 267

5.125 University of Chicago Company Overview 269

5.125.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 269

5.126 University of Iowa Company Overview 270

5.126.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 270

5.127 University of Montreal Company Overview 271

5.127.1 University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 271

5.128 University of Nebraska Company Overview 272

5.128.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 272

5.129 University of Nebraska Medical Center Company Overview 273

5.129.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview 273

5.130 Varian Medical Systems Inc Company Overview 274

5.130.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 274

5.131 Vigor Medical Technologies Ltd. Company Overview 275

5.131.1 Vigor Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 275

5.132 Virginia Polytechnic Institute and State University Company Overview 276

5.132.1 Virginia Polytechnic Institute and State University Pipeline Products & Ongoing Clinical Trials Overview 276

5.133 Vivonics Inc Company Overview 277

5.133.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 277

5.134 VytronUS Inc Company Overview 278

5.134.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 278

5.135 Xeltis AG Company Overview 281

5.135.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 281

6 Cardiovascular Surgery Devices- Recent Developments 284

6.1 Jan 19, 2023: Torbjörn Sköld Appointed New CEO of Stille AB 284

6.2 Jan 12, 2023: Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer 284

6.3 Jan 09, 2023: MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates 285

6.4 Jan 09, 2023: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022 287

6.5 Jan 05, 2023: New study of self-forming magnetic anastomosis compared to stapler demonstrates improved anastomosis healing qualities in a pre-clinical study 288

6.6 Jan 03, 2023: MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer 288

6.7 Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference 289

6.8 Dec 20, 2022: Bioretec’s financial information and Annual General Meeting in 2023 289

6.9 Dec 20, 2022: Icahn School of Medicine : Digital marker for coronary artery disease built by researchers at Mount Sinai 289

6.10 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 290

6.11 Dec 08, 2022: MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics 291

6.12 Dec 06, 2022: EndoGastric Solutions Announces CEO Transition 292

6.13 Nov 23, 2022: Medtronic Reports Quarterly Earnings 293

6.14 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 293

6.15 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 298

6.16 Nov 10, 2022: Study finds catheter ablation significantly lowers risk of dementia in patients with atrial fibrillation 298

6.17 Nov 07, 2022: SI-Bone Reports Financial Results for the Third Quarter 2022 and Updates Guidance 299

6.18 Nov 07, 2022: Fortis Malar Hospitals Announces Unaudited Standalone and Consolidated Financial Results for the Quarter Ended September 30, 2022 301

6.19 Oct 28, 2022: Medistim Third quarter results 2022 301

6.20 Oct 27, 2022: Stille Announces Interim Report Q3 2022 301

6.21 Oct 21, 2022: Elos Medtech Interim Report January 1 – September 30, 2022 301

6.22 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022 302

6.23 Oct 17, 2022: SI-BONE to Report Third Quarter 2022 Financial Results on November 7, 2022 302

6.24 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022 302

6.25 Oct 14, 2022: Elos Medtech Nomination Committee appointed for the 2023 Annual General Meeting 302

6.26 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 303

6.27 Oct 12, 2022: Freudenberg Medical expands handle design center of excellence 304

6.28 Oct 12, 2022: Cardiovascular Systems to Host Earnings Conference Call on November 3, 2022 304

6.29 Oct 11, 2022: AtriCure to Announce Third Quarter 2022 Financial Results 304

6.30 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.”s International Business 305

6.31 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment 305

6.32 Sep 29, 2022: Artivion AORT Appoints Elizabeth Hoff to its Board 305

6.33 Sep 23, 2022: Getinge appoints Joanna Engelke as new Executive Vice President Quality Compliance, Regulatory & Medical Affairs and member of the Getinge Executive Team 305

6.34 Sep 07, 2022: Medtronic to appear at September investor conferences 305

6.35 Sep 06, 2022: MiMedx Announces Leadership Transition 306

6.36 Sep 05, 2022: Sanofi announce Evolution of the Board of Directors 307

6.37 Sep 05, 2022: Elos Medtech appoints new President & CEO and Chairman of the Board 307

6.38 Aug 31, 2022: LeMaitre to Present at the Morgan Stanley 20th Annual Global Healthcare Conference 307

6.39 Aug 25, 2022: Atrion Announces CFO Succession Plan 308

6.40 Aug 24, 2022: Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase 308

6.41 Aug 23, 2022: SI-BONE To Present at The Morgan Stanley 20th Annual Global Healthcare Conference 308

6.42 Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022 308

6.43 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 309

6.44 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 311

6.45 Aug 20, 2022: Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 314

6.46 Aug 17, 2022: Mallinckrodt Announces Appointment of Karen Ling to Its Board of Directors 314

6.47 Aug 16, 2022: AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 315

6.48 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 315

6.49 Aug 10, 2022: Medline releases 2021 Corporate Social Responsibility Report 315

6.50 Aug 08, 2022: SI-BONE Reports Financial Results for the Second Quarter 2022 316

6.51 Aug 02, 2022: MIMEDX Announces Second Quarter 2022 Operating and Financial Results 317

6.52 Aug 02, 2022: AtriCure Reports Second Quarter 2022 Financial Results 319

6.53 Aug 02, 2022: First-in-human trial shows promise for hard-to-treat ventricular tachycardia heart rhythms 320

6.54 Aug 02, 2022: Fortis Malar Hospitals Announces Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2022. 321

6.55 Aug 01, 2022: Audrey Derveloy appointed President of Sanofi France 321

6.56 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 322

6.57 Jul 28, 2022: Sanofi’s half-year financial report for 2022 323

6.58 Jul 28, 2022: LeMaitre Q2 2022 Financial Results 323

6.59 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022 324

6.60 Jul 27, 2022: MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts 325

6.61 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 329

6.62 Jul 20, 2022: AtriCure to Participate at Upcoming Investor Conferences 329

6.63 Jul 18, 2022: SI-BONE To Report Second Quarter 2022 Financial Results on August 8, 2022 330

6.64 Jul 18, 2022: SI-BONE to Present at The Canaccord Genuity 42nd Annual Growth Conference 2022 330

6.65 Jul 18, 2022: LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022 330

6.66 Jul 15, 2022: Stille AB: Interim Report Q2 2022 330

6.67 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022 331

6.68 Jul 12, 2022: AtriCure to Announce Second Quarter 2022 Financial Results 331

6.69 Jul 04, 2022: Getinge announces its Q2 Report 2022 on July 19 at 08:00 CEST followed by a conference call at 10:00 CEST 331

6.70 Jun 28, 2022: Nipro Notice of Resolutions at the 69th Annual General Meeting of Shareholders 332

6.71 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 333

6.72 Jun 07, 2022: MIMEDX Shareholders Vote to Approve all Proposals at the 2022 Annual Meeting 333

6.73 Jun 07, 2022: Cardiovascular Systems chief operating officer Rhonda Robb exits company 334

6.74 Jun 01, 2022: AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer 334

6.75 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 334

6.76 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 334

6.77 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference 334

6.78 May 16, 2022: MIMEDX Mails Letter to Shareholders 335

6.79 May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share 339

6.80 May 12, 2022: Bioretec enters into a distribution agreement with AMI Medical Technologies for bioresorbable activa products in Israel 339

6.81 May 11, 2022: Hilco Redevelopment partners announces Integra to occupy new Braintree facility 340

6.82 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results 340

6.83 May 09, 2022: SI-BONE Reports First Quarter 2022 Financial Results 341

6.84 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 342

6.85 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 343

6.86 Apr 28, 2022: Stille AB: Interim Report Q1 2022 343

6.87 Apr 28, 2022: LeMaitre Q1 2022 Financial Results 344

6.88 Apr 28, 2022: Osteopore announces appointment of chief operating officer 345

6.89 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022 346

6.90 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 347

6.91 Apr 26, 2022: Resolutions at Getinge’s Annual General Meeting 26 April 2022 349

6.92 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results 350

6.93 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition 350

6.94 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022 351

6.95 Apr 18, 2022: SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022 351

6.96 Apr 18, 2022: SI-BONE To Present at BofA Securities 2022 Healthcare Conference 351

6.97 Apr 15, 2022: LeMaitre Will Announce First Quarter 2022 Earnings Results April 28, 2022 351

6.98 Apr 14, 2022: Leading Quantum Scientist Prineha Narang Appointed to Named Professorship at UCLA 352

6.99 Apr 13, 2022: Resolutions of Bioretec Annual General Meeting and the organizing meeting of the Board of Directors 353

6.100 Apr 11, 2022: AtriCure to Announce First Quarter 2022 Financial Results 354

6.101 Apr 08, 2022: Getinge announces its Q1 Report 2022 on April 26 at 08:00 CEST followed by a conference call at 10:00 CEST 354

6.102 Mar 31, 2022: Imricor adds 15th site and first in Italy 355

6.103 Mar 31, 2022: MicroPort announces annual results for 2021 356

6.104 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis 358

6.105 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022 359

6.106 Feb 28, 2022: MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results 359

6.107 Feb 25, 2022: Getinge introduces a flexible workplace deal for employees in the UK and Ireland 362

6.108 Feb 24, 2022: LeMaitre Q4 2021 Financial Results 362

6.109 Feb 15, 2022: Robert Wood Johnson University Hospital Appoints Dr. Courtney Vose as Chief Nursing Officer 363

6.110 Feb 11, 2022: LeMaitre Will Announce Fourth Quarter 2021 Earnings Results February 24, 2022 364

6.111 Feb 07, 2022: Fortis Malar Hospitals Announces unaudited standalone and consolidated financial results for the quarter and period ended December 31, 2021 364

7 Appendix 365

7.1 Methodology 365

7.2 About GlobalData 368

7.3 Contact Us 368

7.4 Disclaimer 368

Table

Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 25

Cardiovascular Surgery Devices – Pipeline Products by Segment 26

Cardiovascular Surgery Devices – Pipeline Products by Territory 27

Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 28

Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 29

Cardiovascular Surgery Devices – Ongoing Clinical Trials 30

Cardiovascular Surgery Devices Companies – Pipeline Products by Stage of Development 31

Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 36

3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 41

Venous Pressure Preconditioning Device – Product Status 41

Venous Pressure Preconditioning Device – Product Description 41

510 Kardiac Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Lim Transseptal System – Product Status 42

Lim Transseptal System – Product Description 42

Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Expandable Sheath – Heart Failure – Product Status 43

Expandable Sheath – Heart Failure – Product Description 43

AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 44

AutoBlator – Product Status 44

AutoBlator – Product Description 44

CircumBlator AF Catheter Ablation System – Product Status 45

CircumBlator AF Catheter Ablation System – Product Description 45

AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

PFA Pulsed Electric Field Ablation System – Product Status 46

PFA Pulsed Electric Field Ablation System – Product Description 46

Transseptal Kit – Product Status 47

Transseptal Kit – Product Description 47

Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 48

AcQBlate Force Sensing Ablation Catheter – Product Status 48

AcQBlate Force Sensing Ablation Catheter – Product Description 48

Acutus Medical Inc – Ongoing Clinical Trials Overview 49

AcQBlate Force Sensing Ablation Catheter – The Pulsed Field Ablation System Study for Atrial Fibrillation (PFA-AF) 50

Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

iCLAS System – Product Status 51

iCLAS System – Product Description 51

PFCA System – Product Status 52

PFCA System – Product Description 52

Adagio Medical Inc. – Ongoing Clinical Trials Overview 53

iCLAS System – A First-in-human Study of Pulsed Field Cryoablation for the Treatment of Patients with Atrial Fibrillation 54

iCLAS System – Cryoablation for Monomorphic Ventricular Tachycardia Early Feasibility Study (EFS) 54

iCLAS System – iCLAS Cryoablation System Post-Market Clinical Follow-up (PMCF) Study 54

iCLAS System – iCLAS for Persistent Atrial Fibrillation 55

iCLAS System – PARALELL – Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation 55

iCLAS System – vCLAS™ Cryoablation for Monomorphic Ventricular Tachycardia 55

PFCA System – PARALELL – Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation 56

Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 57

Thrombectomy Device – Product Status 57

Thrombectomy Device – Product Description 57

AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 58

CardioPass – Product Status 58

CardioPass – Product Description 58

Affera Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Affera Mapping and Ablation System – Product Status 59

Affera Mapping and Ablation System – Product Description 59

HexaGEN Ablation System – Product Status 60

HexaGEN Ablation System – Product Description 60

Sphere9 Catheter – Product Status 60

Sphere9 Catheter – Product Description 61

SpherePVI – Product Status 61

SpherePVI – Product Description 61

Affera Inc – Ongoing Clinical Trials Overview 62

Sphere9 Catheter – Study to Evaluate the Safety and Efficacy of Lattice Sphere Catheter to Reduce Complication Risk During Cardiac Ablation 63

Affera Mapping and Ablation System – First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation 64

SpherePVI – A Safety and Performance Assessment of the Affera SpherePVI Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation 65

SpherePVI – A Safety and Performance Assessment of the SpherePVI Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation 65

SpherePVI – First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation 65

AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

Tip-Catheter – Product Status 66

Tip-Catheter – Product Description 66

Amt Medical BV Pipeline Products & Ongoing Clinical Trials Overview 67

ELANA Heart Bypass System – Product Status 67

ELANA Heart Bypass System – Product Description 67

Amt Medical BV – Ongoing Clinical Trials Overview 68

ELANA Heart Bypass System – A First-in-Human (FIH) Study of ELANA Heart Bypass Solution 69

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Non-Thermal Vein Ablation Device – Product Status 70

Non-Thermal Vein Ablation Device – Product Description 70

Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 71

Anastomotic Suturing Connector – Product Status 71

Anastomotic Suturing Connector – Product Description 71

ApiCor – Product Status 72

ApiCor – Product Description 72

EasyApex CV – Product Status 72

EasyApex CV – Product Description 73

Endo LV – Product Status 73

Endo LV – Product Description 73

Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 74

Next Generation Cardiac Surgical Device – Product Status 74

Next Generation Cardiac Surgical Device – Product Description 74

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Pulse Ablation Generator – Product Status 75

Pulse Ablation Generator – Product Description 75

Ring Pulse Ablation Catheter – Product Status 76

Ring Pulse Ablation Catheter – Product Description 76

Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview 77

Coherent Sine-Burst Electroporation Ablation System – Product Status 77

Coherent Sine-Burst Electroporation Ablation System – Product Description 77

Non-Thermal Cardiac Ablation System – Product Status 78

Non-Thermal Cardiac Ablation System – Product Description 78

Arga Medtech SA – Ongoing Clinical Trials Overview 79

Coherent Sine-Burst Electroporation Ablation System – Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients with Atrial Fibrillation 80

ArtiFex Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 81

ArtiFex Vascular Graft – Product Status 81

ArtiFex Vascular Graft – Product Description 81

Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

mPEF Device – Atrial Fibrillation – Product Status 82

mPEF Device – Atrial Fibrillation – Product Description 82

Atrian Medical Ltd – Ongoing Clinical Trials Overview 83

mPEF Device – Atrial Fibrillation – Atrial Deganglionation as a Therapy for Cardiac Surgery Patients With Atrial Fibrillation 84

mPEF Device – Atrial Fibrillation – Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation 84

AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 85

AtriClip System – Stroke – Product Status 85

AtriClip System – Stroke – Product Description 85

AtriCure Bipolar System – Product Status 86

AtriCure Bipolar System – Product Description 86

AtriCure Isolator Synergy Surgical Ablation System – Inappropriate Sinus Tachycardia (IST) – Product Status 86

AtriCure Isolator Synergy Surgical Ablation System – Inappropriate Sinus Tachycardia (IST) – Product Description 87

AtriCure Inc – Ongoing Clinical Trials Overview 88

AtriClip System – Stroke – Stand-alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion with AtriClip Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation – the Polish Nationwide Registry 89

AtriCure Bipolar System – Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation 90

Axcelon Biopolymers Corp Pipeline Products & Ongoing Clinical Trials Overview 91

BNC – PVA Based Vascular Graft – Product Status 91

BNC – PVA Based Vascular Graft – Product Description 91

Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 92

Satera Ablation System – Product Status 92

Satera Ablation System – Product Description 92

Axon Therapies Inc – Ongoing Clinical Trials Overview 93

Satera Ablation System – Endovascular Ablation of the Right Greater Splanchnic Nerve in Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF: Feasibility Study: Randomized Controlled Feasibility Trial – Rebalance-HF Study 94

Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Cardiac Ablation Mitigating Device – Product Status 95

Cardiac Ablation Mitigating Device – Product Description 95

Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 96

Pericardial Reinforcement Device – Product Status 96

Pericardial Reinforcement Device – Product Description 96

Tissue Transplant And Regeneration Device – Product Status 97

Tissue Transplant And Regeneration Device – Product Description 97

Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 98

VARIPULSE Catheter – Product Status 98

VARIPULSE Catheter – Product Description 98

Biosense Webster Inc – Ongoing Clinical Trials Overview 99

VARIPULSE Catheter – Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE) 100

VARIPULSE Catheter – Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE) 100

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 101

Heart Patch Deployment System – Product Status 101

Heart Patch Deployment System – Product Description 101

Millimeter-Scale Device – Product Status 102

Millimeter-Scale Device – Product Description 102

Mitral Valve Repair Clip Delivery Device – Product Status 102

Mitral Valve Repair Clip Delivery Device – Product Description 103

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 104

WM NG Sheath – Product Status 104

WM NG Sheath – Product Description 104

CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 105

Plexisyl-AF – Product Status 105

Plexisyl-AF – Product Description 105

CardioPrecision Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

CardioPrecision Device – Product Status 106

CardioPrecision Device – Product Description 106

CardioScout, LLC Pipeline Products & Ongoing Clinical Trials Overview 107

Minimally Invasive Surgical Device – Product Status 107

Minimally Invasive Surgical Device – Product Description 107

Cardious Inc Pipeline Products & Ongoing Clinical Trials Overview 108

AvA Aortic Valve Bypass Graft System – Product Status 108

AvA Aortic Valve Bypass Graft System – Product Description 108

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 109

IVL System – Product Status 109

IVL System – Product Description 109

catheter precision Inc Pipeline Products & Ongoing Clinical Trials Overview 110

Vessel Closure Device – Product Status 110

Vessel Closure Device – Product Description 110

Centre Hospitalier Universitaire de Nice Pipeline Products & Ongoing Clinical Trials Overview 111

Shark Anastomosis Connector – Product Status 111

Shark Anastomosis Connector – Product Description 111

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 112

Right Angle Cannula – Product Status 112

Right Angle Cannula – Product Description 112

CircumFix Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 113

Sternal Closure Device – Product Status 113

Sternal Closure Device – Product Description 113

Corazon Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114

Beating Heart Aortic Valve Repair Demineralization System – Product Status 114

Beating Heart Aortic Valve Repair Demineralization System – Product Description 114

Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 115

HeArTPAD – Product Status 115

HeArTPAD – Product Description 115

Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 116

Cardiac Sympathetic Denervation Device – Product Status 116

Cardiac Sympathetic Denervation Device – Product Description 116

Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 117

Distal Anastomosis Device – Product Status 117

Distal Anastomosis Device – Product Description 117

Proximal Anastomosis Device – Product Status 118

Proximal Anastomosis Device – Product Description 118

CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 119

ICEolate Catheter – Product Status 119

ICEolate Catheter – Product Description 120

ICEolate Catheter With Spot Ablation Tip – Product Status 120

ICEolate Catheter With Spot Ablation Tip – Product Description 120

ICEolate Surgical Probe With Control Handle – Product Status 121

ICEolate Surgical Probe With Control Handle – Product Description 121

ICEolate Surgical Probe With Flexible Ablation Tip – Product Status 121

ICEolate Surgical Probe With Flexible Ablation Tip – Product Description 122

Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 123

AF Cryoablation System – Product Status 123

AF Cryoablation System – Product Description 123

Cryo-RDN System – Product Status 124

Cryo-RDN System – Product Description 124

Pulmonary Hypertension Cryoablation System – Product Status 124

Pulmonary Hypertension Cryoablation System – Product Description 125

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 126

Cytograft Device – Percutaneous Bypass – Product Status 126

Cytograft Device – Percutaneous Bypass – Product Description 126

LifeLine TEBV – CABG – Product Status 127

LifeLine TEBV – CABG – Product Description 127

Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 128

Repair Rings Applicator – Product Status 128

Repair Rings Applicator – Product Description 128

Sutureless Cannula – Product Status 129

Sutureless Cannula – Product Description 129

Sutureless Natural Vascular Connector – Product Status 129

Sutureless Natural Vascular Connector – Product Description 130

Sutureless Vascular Synthetic Graft Connector – Product Status 130

Sutureless Vascular Synthetic Graft Connector – Product Description 130

Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 131

APTURE – Product Status 131

APTURE – Product Description 131

ESSANA – Product Status 132

ESSANA – Product Description 132

FORETELL – Product Status 132

FORETELL – Product Description 132

Next-Gen EndoVent With Pacing – Product Status 133

Next-Gen EndoVent With Pacing – Product Description 133

Next-Gen QuickDraw Cannula – Product Status 133

Next-Gen QuickDraw Cannula – Product Description 133

Sutrafix – Product Status 134

Sutrafix – Product Description 134

Elana bv Pipeline Products & Ongoing Clinical Trials Overview 135

ELANA CLIP 3.0 – Product Status 135

ELANA CLIP 3.0 – Product Description 135

Emory University Pipeline Products & Ongoing Clinical Trials Overview 136

CorAccess – Product Status 136

CorAccess – Product Description 136

Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

Zeroneck – Abdominal Aortic Aneurysm – Product Status 137

Zeroneck – Abdominal Aortic Aneurysm – Product Description 137

enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 138

CoreoGraft – Product Status 138

CoreoGraft – Product Description 138

enVVeno Medical Corp – Ongoing Clinical Trials Overview 139

CoreoGraft – First-in-human Trial Evaluating the Efficacy of CoreoGraft in the Coronary Artery Bypass Graft (CABG) Surgery 140

Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview 141

EpiEndoAF Device – Product Status 141

EpiEndoAF Device – Product Description 141

EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142

Epicardial Access Trocar – Product Status 142

Epicardial Access Trocar – Product Description 142

Excision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 143

Leaflet Modification System – Product Status 143

Leaflet Modification System – Product Description 143

Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Endo Faraflex – Product Status 144

Endo Faraflex – Product Description 144

Endo Farapoint – Product Status 145

Endo Farapoint – Product Description 145

Epi Faraone – Product Status 145

Epi Faraone – Product Description 146

FARAPULSE PFA System – Product Status 146

FARAPULSE PFA System – Product Description 146

Next Gen FARAWAVE Catheter – Product Status 147

Next Gen FARAWAVE Catheter – Product Description 147

Farapulse Inc – Ongoing Clinical Trials Overview 148

FARAPULSE PFA System – A Prospective Randomized Pivotal Trial of the FARAPULSE Pulsed Field Ablation System Compared with Standard of Care Ablation in Patients with Paroxysmal Atrial Fibrillation 149

FARAPULSE PFA System – A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation 149

FARAPULSE PFA System – A Real-world Study of the FARAPULSE Pulsed Field Ablation System in A Chinese Population With Paroxysmal Atrial Fibrillation 149

FARAPULSE PFA System – PersAFOne II(Pronounced Per-‘Se-fa-ne 2); Feasibility Study of the FARAPULSE Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation 150

FARAPULSE PFA System – PersAFOne III: Feasibility Study of the FARAPULSE Pulsed Field Ablation System Plus – PersAF in the Treatment of Persistent Atrial Fibrillation 150

FARAPULSE PFA System – Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System 150

FARAPULSE PFA System – Single Shot Pulmonary Vein Isolation: Comparison of Cryoballoon vs. Pulsed Field Ablation in Patients With Symptomatic Paroxysmal Atrial Fibrillation – A Multi-Center Non-Inferiority Design Clinical Trial (The SINGLE SHOT CHAMPION Trial) 151

FARAPULSE PFA System – The FARAPULSE FARA-Freedom Trial A Prospective Open Label Single Arm Post Market Clinical Follow-Up Trial of the FARAPULSE Pulsed Field Ablation System in Patients with Paroxysmal Atrial Fibrillation 151

Next Gen FARAWAVE Catheter – The Effect of Pulsed-field and Radiofrequency Ablation for Atrial Fibrillation on Platelet Activity, Coagulation and Inflammation 152

Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 153

Centauri System – Product Status 153

Centauri System – Product Description 153

Galaxy Medical Products Inc – Ongoing Clinical Trials Overview 154

Centauri System – Study Evaluating the Safety and Efficacy of the Centauri system (ECLIPSE-AF) 155

Centauri System – Study Evaluating the Safety and Efficacy of the Centauri System in Patients with Persistent Atrial Fibrillation: SPACE-AF 155

Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview 156

Graft-Loc Device – Product Status 156

Graft-Loc Device – Product Description 156

H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 157

Vascular Stent – Product Status 157

Vascular Stent – Product Description 157

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 158

Cardio Safex – Product Status 158

Cardio Safex – Product Description 158

Qualiblate – Product Status 159

Qualiblate – Product Description 159

Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

Liwen RF Ablation System – Product Status 160

Liwen RF Ablation System – Product Description 160

Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

CardioPulse Field Ablation System – Product Status 161

CardioPulse Field Ablation System – Product Description 161

Hangzhou Nuomao Medical Technology Co Ltd – Ongoing Clinical Trials Overview 162

CardioPulse Field Ablation System – A Prospective, Multicenter, Single-arm Objective Performance Criteria Evaluation of the Safety and Efficacy of a Pulsed Field Ablation System in Patients with Paroxysmal Atrial Fibrillation 163

HeartLander Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164

HeartLander – Product Status 164

HeartLander – Product Description 164

HeartStitch Inc. Pipeline Products & Ongoing Clinical Trials Overview 165

HeartStitch – Remo Pro – Product Status 165

HeartStitch – Remo Pro – Product Description 165

Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 166

Catheter-Based Ablation Device – Product Status 166

Catheter-Based Ablation Device – Product Description 166

Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

Atrial Fibrillation Pulsed Field Ablation System – Product Status 167

Atrial Fibrillation Pulsed Field Ablation System – Product Description 167

iiTech BV Pipeline Products & Ongoing Clinical Trials Overview 168

S² Distal Anastomotic System – Product Status 168

S² Distal Anastomotic System – Product Description 168

S2 Proximal Anastomotic System – Product Status 169

S2 Proximal Anastomotic System – Product Description 169

Insight Lifetech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

Pulsed Field Ablation Catheter – Product Status 170

Pulsed Field Ablation Catheter – Product Description 170

Pulsed Field Ablation System – Product Status 171

Pulsed Field Ablation System – Product Description 171

Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

ALPHA1 Ablation Catheter – Product Status 172

ALPHA1 Ablation Catheter – Product Description 172

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 173

Catheter Guiding Computational Modeling Tool – Product Status 173

Catheter Guiding Computational Modeling Tool – Product Description 173

Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 174

CHS – Coated Globe Mapping And Ablation System – Product Status 174

CHS – Coated Globe Mapping And Ablation System – Product Description 174

Globe Mapping And Ablation System – Product Status 175

Globe Mapping And Ablation System – Product Description 175

Globe PF System – Product Status 176

Globe PF System – Product Description 176

Kardium Inc – Ongoing Clinical Trials Overview 177

Globe Mapping And Ablation System – A Prospective, Non-randomized Clinical Study to Assess the Performance of the Globe Positioning System for Left Atrial Mapping During Cardiac Ablation for the Treatment of Atrial Fibrillation 178

Globe Mapping And Ablation System – An Investigational Clinical Study of Globe Mapping and Ablation System in Treatment of Patients with Atrial Fibrillation 178

Globe Mapping And Ablation System – Clinical Evaluation of Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter 178

Globe Mapping And Ablation System – Prospective, Multi-centre, Observational Registry to Evaluate the Clinical Performance of the Globe Mapping and Ablation System for the Treatment of Atrial Fibrillation 179

Globe Mapping And Ablation System – PULSE-EU – A Prospective, Non-randomized Clinical Pilot Study to Assess Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation 179

Globe PF System – A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe Pulsed Field System for Treating Patients with Symptomatic Paroxysmal or Persistent Atrial Fibrillation 180

LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 181

Quintessential Ventricular Cannula – Product Status 181

Quintessential Ventricular Cannula – Product Description 181

LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 182

XenoSure Biologic Vascular Patch – Product Status 182

XenoSure Biologic Vascular Patch – Product Description 182

LeMaitre Vascular Inc – Ongoing Clinical Trials Overview 183

XenoSure Biologic Vascular Patch – Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair 184

XenoSure Biologic Vascular Patch – Random, Controlled, Single-blinded, Multi-center and Non-inferiority Clinical Study to Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Peripheral Vascular Repair 184

Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

Disposable Delivery Sheath – Product Status 185

Disposable Delivery Sheath – Product Description 185

Disposable Introducing Sheath – Product Status 186

Disposable Introducing Sheath – Product Description 186

Thrombus Protection Device – Product Status 186

Thrombus Protection Device – Product Description 187

LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 188

OmniView Light-Guided Ablation Catheter – Product Status 188

OmniView Light-Guided Ablation Catheter – Product Description 188

McGill University Pipeline Products & Ongoing Clinical Trials Overview 189

Transcatheter Aorta Pulmonary Shunt – Product Status 189

Transcatheter Aorta Pulmonary Shunt – Product Description 189

Medical 21 Inc Pipeline Products & Ongoing Clinical Trials Overview 190

Maverics Graft – Product Status 190

Maverics Graft – Product Description 190

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 191

Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Product Status 191

Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Product Description 192

CryoFlex Surgical Ablation System – Non-Paroxysmal Atrial Fibrillation – Product Status 192

CryoFlex Surgical Ablation System – Non-Paroxysmal Atrial Fibrillation – Product Description 192

PulseSelect PFA System – Product Status 193

PulseSelect PFA System – Product Description 193

Medtronic Plc – Ongoing Clinical Trials Overview 194

Cardioblate Irrigated RF (IRF) System – Non-Paroxysmal Atrial Fibrillation – Irrigated Radio Frequency Ablation to Terminate Non-paroxysmal Atrial Fibrillation: Terminate AF Study 195

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 196

Expandable Sheath – Product Status 196

Expandable Sheath – Product Description 196

Femoral Arterial Cannula – Product Status 197

Femoral Arterial Cannula – Product Description 197

Femoral Venous Cannula – Product Status 197

Femoral Venous Cannula – Product Description 198

Microsurgical Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview 199

Vascular Coupling Device – Product Status 199

Vascular Coupling Device – Product Description 199

Most Cardio LLC Pipeline Products & Ongoing Clinical Trials Overview 200

MIS Port – Cardiovascular Diseases – Product Status 200

MIS Port – Cardiovascular Diseases – Product Description 200

Myocardial Assist Systems and Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 201

Sutureless Anastomotic Graft Connection Device – Product Status 201

Sutureless Anastomotic Graft Connection Device – Product Description 201

National Science and Technology Development Agency Pipeline Products & Ongoing Clinical Trials Overview 202

Cardiac Ablation Device – Product Status 202

Cardiac Ablation Device – Product Description 202

Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 203

Neovaso – Product Status 203

Neovaso – Product Description 203

Nido Surgical LLC Pipeline Products & Ongoing Clinical Trials Overview 204

Cardioport – Product Status 204

Cardioport – Product Description 204

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 205

Cardiac Tissue Ablation Device – Product Status 205

Cardiac Tissue Ablation Device – Product Description 205

Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 206

Occlutech Atrial Flow Regulator (AFR) Device – Product Status 206

Occlutech Atrial Flow Regulator (AFR) Device – Product Description 206

Occlutech International AB – Ongoing Clinical Trials Overview 207

Occlutech Atrial Flow Regulator (AFR) Device – A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech Atrial Flow Regulator in Heart Failure Patients 208

Occlutech Atrial Flow Regulator (AFR) Device – Flow Regulation by Opening the SepTum in Patients with Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study 208

Occlutech Atrial Flow Regulator (AFR) Device – Pomeranian Atrial Flow Regulator in Congestive Heart Failure (PROLONGER) Trial 208

Occlutech Atrial Flow Regulator (AFR) Device – Prospective, Non-randomized, Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients with Pulmonary Hypertension 209

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 210

Expandable Sheath – Product Status 210

Expandable Sheath – Product Description 210

Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 211

Caldus – Renal Denervation – Product Status 211

Caldus – Renal Denervation – Product Description 211

Caldus – Traditional Tissue Ablation – Product Status 212

Caldus – Traditional Tissue Ablation – Product Description 212

Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 213

RV-PA Shunt – Product Status 213

RV-PA Shunt – Product Description 213

PeriCor LLC Pipeline Products & Ongoing Clinical Trials Overview 214

PeriPath – Product Status 214

PeriPath – Product Description 214

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 215

Coronary Artery Bypass Graft – Product Status 215

Coronary Artery Bypass Graft – Product Description 215

Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview 216

Snapcon – Product Status 216

Snapcon – Product Description 216

Protaryx Medical Pipeline Products & Ongoing Clinical Trials Overview 217

Protaryx Device – Product Status 217

Protaryx Device – Product Description 217

Rafael Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 218

Space Station – Product Status 218

Space Station – Product Description 218

RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 219

Neo-Vessel Replacement – Coronary Artery Bypass – Product Status 219

Neo-Vessel Replacement – Coronary Artery Bypass – Product Description 219

Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 220

Hydrogel Implant – Vascular Surgery – Product Status 220

Hydrogel Implant – Vascular Surgery – Product Description 220

RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview 221

StentEx – Product Status 221

StentEx – Product Description 221

SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview 222

MySide – Product Status 222

MySide – Product Description 222

Shanghai Antec Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 223

Cryoballoon Ablation System – Product Status 223

Cryoballoon Ablation System – Product Description 223

Pulsed Electric Field Ablation System – Product Status 224

Pulsed Electric Field Ablation System – Product Description 224

Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

Cryoablation Device – Product Status 225

Cryoablation Device – Product Description 225

Shanghai Keku Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 226

Cardiac Ablation Device – Atrial Fibrillation – Product Status 226

Cardiac Ablation Device – Atrial Fibrillation – Product Description 226

Cardiac Implant – Atrial Fibrillation – Product Status 227

Cardiac Implant – Atrial Fibrillation – Product Description 227

Shanghai Weiqi Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

Cardiac Cryoablation System – Product Status 228

Cardiac Cryoablation System – Product Description 228

Shanghai Weiqi Medical Equipment Co Ltd – Ongoing Clinical Trials Overview 229

Cardiac Cryoablation System – A Prospective, Multicenter, Single-arm Clinical Trial Evaluating the Safety and Efficacy of a Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillat

Figures

Cardiovascular Surgery Devices – Pipeline Products by Stage of Development 25

Cardiovascular Surgery Devices – Pipeline Products by Segment 26

Cardiovascular Surgery Devices – Pipeline Products by Territory 27

Cardiovascular Surgery Devices – Pipeline Products by Regulatory Path 28

Cardiovascular Surgery Devices – Pipeline Products by Estimated Approval Date 29

Cardiovascular Surgery Devices – Ongoing Clinical Trials 30

Frequently asked questions

Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cardiovascular Surgery Devices Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.